BJU International

Article	Citations
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati	96
Response to Chen et al.	84
Building a research profile during residency	66
The European Association of Urology talent incubator: bridging competencies for holistic urological care	58
April's reviewers of the month	56
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	53
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	53
	48
April's reviewers of the month	47
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	46
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	46
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	44
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	42
Recent key papers in prostate cancer	42
The LANDMARK project: providing summaries of key papers that have shaped urological practice	42
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents	42
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	39
Editorial Board	37
	37
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	37
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer	34
Author Index	33
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’	32
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses	30
September's reviewers of the month	29

Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study	29
MRI , Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?	28
Eve's and Adam's rib for prostate cancer screening	27
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.3	26
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing	26
Journal information	25
Editorial Board	25
Is Artificial Intelligence Ready for “Primetime” in Urology?	25
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit	24
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography ( PSMA‐PET) and magnetic resonance imaging (	24
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents	24
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes	23
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	23
Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality	22
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	21
Corrigendum	21
Thulium fibre laser lithotripsy, the new standard?	21
Can only AI save us from the burden of administration?	21
A meta‐analysis of Retzius‐sparing and hood‐technique robot‐assisted radical prostatectomy	21
The effect of different assays on prostate‐specific antigen testing	21
Can exercise increase natural killer cell infiltration of the prostate?	21
Sexual function in adolescence after childhood hypospadias repair: a patient‐reported outcome study	21
Should patients with non‐muscle‐invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette–Guérin?	21
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study	21
	20
September's reviewers of the month	20
Table of Contents	20
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function	20
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial	20
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT	19
	19
August's reviewers of the month	19
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter	19
Editorial Board	18
	18
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway	18
Caval thrombectomy a urological leap into the unknown – a call for action	18
Issue Information	17
Is Gleason 6 cancer? The answer is more than just a ‘name’	17
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	17
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐ less	17
Sustainability in urology – are we doing enough?	17
Reply to ‘A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer’ by Su et al.	17
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours	17
Progress in the management of stone disease	17
Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure	17
The rapid assessment for prostate imaging and diagnosis ( RAPID ) prostate cancer diagnostic pathway	16
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients	16
Correction to “Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer”	16
Preferences between three options for androgen deprivation therapy: a focus group study	16

Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review	16
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy	16
Editorial Board	15
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety	15
Journal information	15
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults	15
‘ Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and ne	15
	15
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia	15
Cystectomy and lymphadenectomy – we now node how far to go!	15
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	15
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer	15
Definitive local therapy for T4 prostate cancer associated with improved local control and survival	15
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’	15
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	15
Key ingredients for running a randomised controlled trial in a surgical day unit	15
Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser	14
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer	14
Development of an optically transparent kidney model for laser lithotripsy research	14
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	14
	14
Pre‐versus postnatal presentation of posterior urethral valves: a multi‐institutional experience	14
Issue Information	14
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor	14
Editorial Board	14
Comment on ‘Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management’	13
Evaluating the predictors of poor corporal integrity in penile implant recipients	13
Re‐defining the interpretation of 24‐h urine studies for stone formers	13
Issue Information	13
Hydraulic and malleable female‐to‐male penile implants after phalloplasty in transgender individuals: a retrospective cohort analysis	13
Editorial Board	13
Journal information	13
Clinical presentation of bacille Calmette–Guérin ( BCG ) infections after	13
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease	13
Scribe smarter, not harder: how artificial intelligence scribes stack up against human clinicians	13
	13
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users	13
	12
Ureteric stenting after uncomplicated ureteroscopy: a systematic review of surgeons’ motivations and patient experiences	12
High prostate‐specific membrane antigen ( PSMA) positron emission tomography (PET) maximum standardized uptake value in men	12
Deep learning‐based classification of acute scrotum using single ultrasound images	12
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study	12
The importance of the urologist in male oncology fertility preservation	12
Response to Zhu et al.	12
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique	12
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study	12
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney	12
Developing an artificial intelligence model for phase recognition in robot‐assisted radical prostatectomy	12
An MRI/PET PSMA‐based phase I–II study of salvage high‐dose‐rate brachytherapy after surgery and radiotherapy	12
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer	12
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	12
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function	12
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours	11
Stone volume instead of maximum stone diameter: results from an international survey	11
Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation	11
Emergency department visits for radiation cystitis among patients with a prostate cancer history	11
Comment on ‘Can ChatGPT pass the urology fellowship examination? Artificial intelligence capability in surgical training assessment’	11
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial	11
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty	11
Cisplatin‐ineligible patients with muscle‐invasive bladder cancer demonstrate poor long‐term survival following immediate radical cystectomy	11
Perspectives on technology: Single‐use catheters – evidence and environmental impact	11
November's reviewers of the month	11
Complete response in metastatic renal cell carcinoma: impact of a persistent primary lesion	11
There is more to disposable endoscopes than whether they work…	11
Greenlight laser prostatectomy: which goggles are best for visualising haematuria accurately?	11
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review	11
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	11
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐	11
Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre	11
The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer	11
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial	11
Issue Information	11
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia	10
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging	10
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?	10
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups	10
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis	10
Global Urology, Urolink, and the BJUI	10
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc	10
Outcomes after laser enucleation of the prostate with and without significant storage symptoms	10

Table of Contents	10
Acute Urinary Retention and Cancer; Is It All About the Prostate?	10
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy	10
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation	10
Table of Contents	10
Recommendation on the use of protective eyewear in endourological laser procedures	10
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma	10
Neural monitoring of central responses to lower urinary tract function	10
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy	9
Systematic review of PSA reference intervals in the gender diverse population with prostates	9
June's reviewers of the month	9
Issue Information	9
August's reviewers of the month	9
January’s reviewers of the month	9
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer	9
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy	9
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2	9
First‐line programmed death receptor‐1 ( PD ‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemothe	9
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer	9
Editorial Board	9
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients	9
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience	9
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort	9
Stapled vs totally handsewn robotic intracorporeal neobladder: perioperative and functional outcomes	8
Editorial Board	8
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during	8
Nomograms including the UBC ® Rapid test to detect primary bladder cancer based on a multicentre dataset	8
Editorial Board	8
Comment on ‘Stone dust in endourology: a systematic review of its definition, management, and clinical impact’	8
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer	8
A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer	8
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’	8
Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence	8
Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder	8
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial	8
A randomised trial comparing transurethral to percutaneous cystolithotripsy in boys	8
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome	8
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management	8
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade	8
The first step in shared decision‐making for prostate cancer screening	8
	8
Re: ‘The perioperative outcomes of papillary versus non‐papillary access in percutaneous nephrolithotomy’	8
Economic analysis of minimally invasive surgical treatments for BPH in the Australian public healthcare system	8
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer	8
Impact of perioperative nutrition on recovery after radical cystectomy: a randomised trial	8
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency	8
Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy	7
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time	7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy	7
	7
Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment	7
Villis Marshall Presentation	7
Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy	7
Is solo indocyanine green‐guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?	7
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’	7
Cystoscopic application of RADA16 peptide for refractory haematuria from radiation cystitis	7
B ladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate	7
	7
Perspectives on technology: All STEPS count – an integrated framework for net zero urological care	7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis	7
Comment on: ‘Preferences between three options for androgen deprivation therapy…’	7
Low‐ versus standard‐ pneumoperitoneum in patients undergoing robot‐assisted radical prostatectomy: a randomised, triple‐blinded study	7
Concurrent Session Presentations	7
Journal information	7
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer	7
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction	7
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury	7
Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet ® ) with radical prostatectomy and adjuvant externa	7
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer	7
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses	7
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care	7
Is genetic testing coming of age in advanced prostate cancer?	7
Technetium‐99 m‐sestamibi single‐photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses	7
Comment on ‘Renal, bladder and prostate cancer surgery outcomes with respect to team familiarity’	7
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?	7
Keith Kirkland Presentation	7
The growing valuable role of urology clinical nurse specialists in the United Kingdom	7
	7
Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial	7
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas	7
Abstract	7
Table of Contents	7
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy	7
Comment on ‘Chatbots in urology: accuracy, calibration, and comprehensibility; is DeepSeek taking over the throne?’	6
Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy	6
Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta‐analysis	6
Positive surgical margins in partial nephrectomy: a collaborative effort to maintain surgical quality	6
Awareness and perspectives on hereditary renal cell carcinoma and genetic testing in clinical practice: a multi‐national survey	6
Local recurrence after glans‐sparing surgery: no impact on penile cancer‐specific survival	6
Electronic medical records – a disappointing mirage for clinicians and research	6
Continence criteria of 193 618 patients after open, laparoscopic, and robot‐assisted radical prostatectomy	6
Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports	6
Response to Takahashi	6
Three‐dimensional virtual reconstruction guides robot‐assisted partial nephrectomy in a horseshoe kidney	6
Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study	6